Karyopharm Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Karyopharm Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$32.1M, a 7.05% increase year-over-year.
  • Karyopharm Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$87.5M, a 37.4% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$143M, a 13.4% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$165M, a 33.2% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$124M, a 36.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$143M +$22.2M +13.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$165M -$41.2M -33.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$124M +$72.2M +36.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$196M +$3.32M +1.66% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$200M -$21.2M -11.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$178M -$49.4M -38.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$129M -$19.4M -17.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$110M +$8.6M +7.28% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$118M -$42.4M -56% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$75.8M -$41.8M -123% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$33.9M -$18.1M -114% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$15.9M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.